Literature DB >> 23489151

Paracetamol overdose in Victoria remains a significant health-care burden.

Siddharth Sood1, Jessica Howell, Vijaya Sundararajan, Peter W Angus, Paul J Gow.   

Abstract

BACKGROUND AND AIM: Paracetamol is the most frequently used analgesic in Australia and can be purchased without a prescription. We aimed to investigate the epidemiology and outcome of paracetamol overdoses occurring in Victoria, Australia.
METHODS: The Victorian admitted episode dataset was examined for all patients who had a diagnosis of paracetamol poisoning (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification [ICD-10-AM]: T39.1) or paracetamol adverse effect in therapeutic use (Y45.5) from July 1, 2000 to June 30, 2007. Data extracted included all ICD-10 codes related to their admissions, gender, age range, date of admission, and cause of death (if applicable).
RESULTS: Over 7 years, there was a total of 14,662 hospital admissions for paracetamol overdose with a mean of 2095 cases per year. Accidental overdoses comprised 15% (n = 2149) of cases. The overdose rate fell from 46 cases per 100,000 in 2001 to 39 cases per 100,000 in 2006 (P < 0.001). Most overdoses occurred in women (71%), and patients between 15 and 50 years old comprised 78% of all cases. Complications and mortality were relatively uncommon, with only 26 deaths directly attributable to paracetamol overdose over the 7 years. No child under 15 years old died from their overdose.
CONCLUSION: Admission to Victorian hospitals with paracetamol overdose presents an enormous and in many cases preventable health-care burden. Fortunately, there has been a gradual fall in admissions, and most cases appear relatively benign. Further reductions in overdose could be achieved with increased awareness by physicians and the general public regarding the potential for accidental overdose, and increasing funding for mental health initiatives.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Australia; Victoria; acetaminophen; overdose

Mesh:

Substances:

Year:  2013        PMID: 23489151     DOI: 10.1111/jgh.12196

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  What is the Effect of Paracetamol (Acetaminophen) Ingestion on Exercise Performance? Current Findings and Future Research Directions.

Authors:  Jozo Grgic
Journal:  Sports Med       Date:  2022-01-17       Impact factor: 11.928

2.  Association of prenatal acetaminophen use and acetaminophen metabolites with DNA methylation of newborns: analysis of two consecutive generations of the Isle of Wight birth cohort.

Authors:  Shakiba Eslamimehr; A Daniel Jones; Thilani M Anthony; S Hasan Arshad; John W Holloway; Susan Ewart; Rui Luo; Nandini Mukherjee; Parnian Kheirkhah Rahimabad; Su Chen; Wilfried Karmaus
Journal:  Environ Epigenet       Date:  2022-02-02

3.  Acetaminophen Overdose Enhances Early Cholangiocarcinoma in Opisthorchiasis Hamsters.

Authors:  Pranee Sriraj; Thidarut Boonmars; Ratchadawan Aukkanimart; Atchara Artchayasawat; Glenn N Borlace; Panaratana Ratanasuwan; Benjamabhorn Pumhirunroj
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

4.  Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre.

Authors:  Stephanie M Lau; Treasure M McGuire; Mieke L van Driel
Journal:  BMJ Open       Date:  2016-06-08       Impact factor: 2.692

5.  Acetaminophen use during pregnancy and DNA methylation in the placenta of the extremely low gestational age newborn (ELGAN) cohort.

Authors:  Kezia A Addo; Catherine Bulka; Radhika Dhingra; Hudson P Santos; Lisa Smeester; T Michael O'Shea; Rebecca C Fry
Journal:  Environ Epigenet       Date:  2019-08-06

6.  Epidemiology and outcomes of acute liver failure in Australia.

Authors:  Penelope Hey; Timothy P Hanrahan; Marie Sinclair; Adam G Testro; Peter W Angus; Adam Peterson; Stephen Warrillow; Rinaldo Bellomo; Marcos V Perini; Graham Starkey; Robert M Jones; Michael Fink; Tess McClure; Paul Gow
Journal:  World J Hepatol       Date:  2019-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.